Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 352(1): 175-84, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25369797

ABSTRACT

To date, many anticancer drugs have been developed by directly or indirectly targeting microtubules, which are involved in cell division. Although this approach has yielded many anticancer drugs, these drugs produce undesirable side effects. An alternative strategy is needed, and targeting mitotic exit may be one alternative approach. Localization of phosphorylated barrier-to-autointegration factor (BAF) to the chromosomal core region is essential for nuclear envelope compartment relocalization. In this study, we isolated brazilin from Caesalpinia sappan Leguminosae and demonstrated that it inhibited BAF phosphorylation in vitro and in vivo. Moreover, we demonstrated direct binding between brazilin and BAF. The inhibition of BAF phosphorylation induced abnormal nuclear envelope reassembly and cell death, indicating that perturbation of nuclear envelope reassembly could be a novel approach to anticancer therapy. We propose that brazilin isolated from C. sappan may be a new anticancer drug candidate that induces cell death by inhibiting vaccinia-related kinase 1-mediated BAF phosphorylation.


Subject(s)
Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Benzopyrans/isolation & purification , Benzopyrans/pharmacology , Caesalpinia/chemistry , DNA-Binding Proteins/metabolism , Nuclear Envelope/drug effects , Nuclear Proteins/metabolism , Animals , Antineoplastic Agents/metabolism , Benzopyrans/metabolism , Cell Death/drug effects , Drug Evaluation, Preclinical , HeLa Cells , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Male , Mice , Nuclear Envelope/metabolism , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/metabolism , Telophase/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL